posted
ITER going from $13 to $50 mill on accretive acquisitions....their client contracts are 3-4 years with BIG Pharma client such as AMGEN, Baxter, Schering......very attractive valuation disparity at $7 mill market cap on a Co whose valuation should be $18-25mill min....
IP: Logged |